Clinical Trials Browser

Ependymoma × Nivolumab × 90 days × Clear all

NCT06639607 2026-06-03

PRiME II

Phase 1/2 Not yet recruiting

Diffuse Intrinsic Pontine Glioma, Ependymoma, Medulloblastoma, Recurrence